000 | 01984 a2200601 4500 | ||
---|---|---|---|
005 | 20250517131305.0 | ||
264 | 0 | _c20170310 | |
008 | 201703s 0 0 eng d | ||
022 | _a1744-764X | ||
024 | 7 |
_a10.1080/14740338.2017.1270939 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRolland, Benjamin | |
245 | 0 | 0 |
_aPhone-based safety monitoring of the first year of baclofen treatment for alcohol use disorder: the BACLOPHONE cohort study protocol. _h[electronic resource] |
260 |
_bExpert opinion on drug safety _cFeb 2017 |
||
300 |
_a125-132 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study | ||
650 | 0 | 4 |
_aAlcohol Drinking _xprevention & control |
650 | 0 | 4 |
_aAlcoholism _xdrug therapy |
650 | 0 | 4 | _aAlgorithms |
650 | 0 | 4 |
_aBaclofen _xadministration & dosage |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 |
_aDrug Monitoring _xmethods |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aFrance |
650 | 0 | 4 |
_aGABA-B Receptor Agonists _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aOff-Label Use |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aSurveys and Questionnaires |
650 | 0 | 4 | _aTelephone |
700 | 1 | _aAuffret, Marine | |
700 | 1 | _aLabreuche, Julien | |
700 | 1 | _aLapeyre-Mestre, Maryse | |
700 | 1 | _aDib, Malek | |
700 | 1 | _aKemkem, Aomar | |
700 | 1 | _aGrit, Isabelle | |
700 | 1 | _aDrelon, Marie | |
700 | 1 | _aDuhamel, Alain | |
700 | 1 | _aCabe, Nicolas | |
700 | 1 | _aVabret, François | |
700 | 1 | _aGuillin, Olivier | |
700 | 1 | _aBaguet, Alexandre | |
700 | 1 | _aMasquelier, Céline | |
700 | 1 | _aDervaux, Alain | |
700 | 1 | _aDeheul, Sylvie | |
700 | 1 | _aBordet, Régis | |
700 | 1 | _aCarton, Louise | |
700 | 1 | _aCottencin, Olivier | |
700 | 1 | _aJardri, Renaud | |
700 | 1 | _aGautier, Sophie | |
773 | 0 |
_tExpert opinion on drug safety _gvol. 16 _gno. 2 _gp. 125-132 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1080/14740338.2017.1270939 _zAvailable from publisher's website |
999 |
_c26705761 _d26705761 |